Cancer immunotherapy side effects under the microscope: can patients safely resume treatment?
NCT ID NCT07453342
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study tracks 500 cancer patients who have experienced immune-related side effects from immunotherapy drugs like checkpoint inhibitors. Researchers aim to understand how common these side effects are, how they are managed, and whether it is safe to restart immunotherapy after they resolve. The study also collects blood and tissue samples to explore why side effects happen.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Immune checkpoint inhibitors (drugs like anti-PD-1, anti-PD-L1, anti-CTLA-4)
- What this could lead to
- If successful, this study could help doctors better predict and manage immune-related side effects from cancer immunotherapy, and make safer decisions about restarting treatment.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not apply to all patients or cancer types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE-RELATED ADVERSE EVENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New imaging agent could sharpen cancer detection
- Could a single rituximab infusion tame Immunotherapy's harsh side effects?
- New drug cocktail aims to stop Chemo-Linked nausea before it starts
- Could a painless electrical patch help cancer patients sleep better after surgery?
- Your tongue could reveal cancer: AI study analyzes 4,100 people
- New study aims to predict immunotherapy success in cancer patients